Ameriprise’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,620
| Closed | -$66.2K | – | 4063 |
|
|
2024
Q3 | $66.2K | Buy |
+11,620
| New | +$66.2K | ﹤0.01% | 3857 |
|
|
2023
Q4 | – | Sell |
-69,486
| Closed | -$129K | – | 3907 |
|
|
2023
Q3 | $129K | Sell |
69,486
-110
| -0.2% | -$205 | ﹤0.01% | 3758 |
|
|
2023
Q2 | $191K | Sell |
69,596
-10,539
| -13% | -$29K | ﹤0.01% | 3736 |
|
|
2023
Q1 | $252K | Buy |
80,135
+41,487
| +107% | +$130K | ﹤0.01% | 3655 |
|
|
2022
Q4 | $228K | Sell |
38,648
-7,810
| -17% | -$46.1K | ﹤0.01% | 3671 |
|
|
2022
Q3 | $407K | Buy |
+46,458
| New | +$407K | ﹤0.01% | 3463 |
|